{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:28:31Z","timestamp":1787668111422,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-025-06770-3","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T11:55:05Z","timestamp":1763812505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute oxalate nephropathy seven years post Roux-en-Y gastric bypass surgery without excessive vitamin C intake: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Kyoji","family":"Chiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Ohki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Oshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"issue":"6","key":"6770_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.ekir.2018.07.020","volume":"3","author":"N Lumlertgul","year":"2018","unstructured":"Lumlertgul N, Siribamrungwong M, Jaber BL, Susantitaphong P. Secondary oxalate nephropathy: a systematic review. Kidney Int Rep. 2018;3(6):1363\u201372.","journal-title":"Kidney Int Rep"},{"issue":"6","key":"6770_CR2","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.2215\/CJN.02940608","volume":"3","author":"SH Nasr","year":"2008","unstructured":"Nasr SH, D\u2019Agati VD, Said SM, et al. Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol. 2008;3(6):1676\u201383.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"6770_CR3","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.2215\/CJN.00010111","volume":"6","author":"C Cartery","year":"2011","unstructured":"Cartery C, Faguer S, Karras A, et al. Oxalate nephropathy associated with chronic pancreatitis. Clin J Am Soc Nephrol. 2011;6(8):1895\u2013902.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"6770_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5414\/CN109980","volume":"93","author":"Y Yang","year":"2020","unstructured":"Yang Y, Sharma PD, Nair V, et al. Kidney oxalate crystal deposition in adult patients: a relatively common finding. Clin Nephrol. 2020;93(5):243\u201350.","journal-title":"Clin Nephrol"},{"issue":"1","key":"6770_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s13730-018-0366-6","volume":"8","author":"WV Lin","year":"2019","unstructured":"Lin WV, Turin CG, McCormick DW, Haas C, Constantine G. Ascorbic acid-induced oxalate nephropathy: a case report and discussion of pathologic mechanisms. CEN Case Rep. 2019;8(1):67\u201370.","journal-title":"CEN Case Rep"},{"issue":"2","key":"6770_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/sj.ki.5000107","volume":"69","author":"MB Stokes","year":"2006","unstructured":"Stokes MB. Acute oxalate nephropathy due to ethylene glycol ingestion. Kidney Int. 2006;69(2):203.","journal-title":"Kidney Int"},{"issue":"6","key":"6770_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1172\/JCI101006","volume":"17","author":"EP Ralli","year":"1938","unstructured":"Ralli EP, Friedman GJ, Rubin SH. The mechanism of the excretion of vitamin c by the human kidney. J Clin Invest. 1938;17(6):765\u201370.","journal-title":"J Clin Invest"},{"issue":"6","key":"6770_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/ajcn\/19.5.371","volume":"19","author":"EM Baker","year":"1966","unstructured":"Baker EM, Saari JC, Tolbert BM. Ascorbic acid metabolism in man. Am J Clin Nutr. 1966;19(6):371\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"6770_CR9","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1016\/S0021-9258(18)93840-8","volume":"239","author":"GL Atkins","year":"1964","unstructured":"Atkins GL, Dean BM, Griffin WJ, Watts RW. Quantitative aspects of ascorbic acid metabolism in man. J Biol Chem. 1964;239(9):2975\u201380.","journal-title":"J Biol Chem"},{"issue":"4","key":"6770_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/jamainternmed.2018.7980","volume":"179","author":"SS Waikar","year":"2019","unstructured":"Waikar SS, Srivastava A, Palsson R, et al. Association of urinary oxalate excretion with the risk of chronic kidney disease progression. JAMA Intern Med. 2019;179(4):542\u201351.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"6770_CR11","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.ekir.2025.02.004","volume":"10","author":"S Fargue","year":"2025","unstructured":"Fargue S, Suryavanshi M, Wood KD, et al. Inducing Oxalobacter formigenes colonization reduces urinary oxalate in healthy adults. Kidney Int Rep. 2025;10(5):1518\u201328.","journal-title":"Kidney Int Rep"},{"issue":"12","key":"6770_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1159\/000520286","volume":"52","author":"S Reddy","year":"2021","unstructured":"Reddy S, Bolen E, Abdelmalek M, Lieske JC, Ryan M, Keddis MT. Clinical outcomes and histological patterns in oxalate nephropathy due to enteric and nonenteric risk factors. Am J Nephrol. 2021;52(12):961\u20138.","journal-title":"Am J Nephrol"},{"issue":"7","key":"6770_CR13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.soard.2022.12.032","volume":"19","author":"S Mantziari","year":"2023","unstructured":"Mantziari S, Abboretti F, Favre L, et al. Protein malnutrition after Roux-en-Y gastric bypass: a challenging case and scoping review of the literature. Surg Obes Relat Dis. 2023;19(7):746\u201354.","journal-title":"Surg Obes Relat Dis"},{"issue":"5","key":"6770_CR14","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.surg.2010.11.015","volume":"149","author":"R Kumar","year":"2011","unstructured":"Kumar R, Lieske JC, Collazo-Clavell ML, et al. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery. 2011;149(5):654\u201361.","journal-title":"Surgery"},{"issue":"3","key":"6770_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000449128","volume":"6","author":"V Agrawal","year":"2016","unstructured":"Agrawal V, Wilfong JB, Rich CE, Gibson PC. Reversal of gastric bypass resolves hyperoxaluria and improves oxalate nephropathy secondary to Roux-en-Y gastric bypass. Case Rep Nephrol Dial. 2016;6(3):114\u20139.","journal-title":"Case Rep Nephrol Dial"},{"issue":"1","key":"6770_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jamcollsurg.2010.03.007","volume":"211","author":"BG Duffey","year":"2010","unstructured":"Duffey BG, Alanee S, Pedro RN, et al. Hyperoxaluria is a long-term consequence of Roux-en-Y gastric bypass: a 2-year prospective longitudinal study. J Am Coll Surg. 2010;211(1):8\u201315.","journal-title":"J Am Coll Surg"},{"issue":"2","key":"6770_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0026-0495(83)90221-4","volume":"32","author":"Y Suzuki","year":"1983","unstructured":"Suzuki Y, Ichikawa Y, Saito E, Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism. 1983;32(2):151\u20136.","journal-title":"Metabolism"},{"issue":"3","key":"6770_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/nu10030366","volume":"10","author":"E Letavernier","year":"2018","unstructured":"Letavernier E, Daudon M. Vitamin D, hypercalciuria and kidney stones. Nutrients. 2018;10(3):366. https:\/\/doi.org\/10.3390\/nu10030366.","journal-title":"Nutrients"},{"issue":"6","key":"6770_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3343\/alm.2013.33.6.401","volume":"33","author":"IS Choi","year":"2013","unstructured":"Choi IS, Jung ES, Choi YE, Cho YK, Yang EM, Kim CJ. Random urinary calcium\/creatinine ratio for screening hypercalciuria in children with hematuria. Ann Lab Med. 2013;33(6):401\u20135.","journal-title":"Ann Lab Med"},{"issue":"2","key":"6770_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00198-011-1580-7","volume":"23","author":"AN Jones","year":"2012","unstructured":"Jones AN, Shafer MM, Keuler NS, Crone EM, Hansen KE. Fasting and postprandial spot urine calcium-to-creatinine ratios do not detect hypercalciuria. Osteoporos Int. 2012;23(2):553\u201362.","journal-title":"Osteoporos Int"},{"issue":"1","key":"6770_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1210\/jcem-52-1-111","volume":"52","author":"TJ Hahn","year":"1981","unstructured":"Hahn TJ, Halstead LR, Baran DT. Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab. 1981;52(1):111\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"6770_CR22","unstructured":"Ioannis Ilias, Charalampos Milionis, and Emmanouil Zoumakis. [3] An Overview of Glucocorticoid-Induced Osteoporosis. Endotext. Published online March 19, 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK278968\/."},{"issue":"3\u20134","key":"6770_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.lfs.2009.05.013","volume":"85","author":"MH Kim","year":"2009","unstructured":"Kim MH, Lee GS, Jung EM, Choi KC, Jeung EB. The negative effect of dexamethasone on calcium-processing gene expressions is associated with a glucocorticoid-induced calcium-absorbing disorder. Life Sci. 2009;85(3\u20134):146\u201352.","journal-title":"Life Sci"},{"issue":"2","key":"6770_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1042\/CS20171525","volume":"132","author":"WC Valinsky","year":"2018","unstructured":"Valinsky WC, Touyz RM, Shrier A. Aldosterone, SGK1, and ion channels in the kidney. Clin Sci Lond. 2018;132(2):173\u201383.","journal-title":"Clin Sci Lond"},{"issue":"3","key":"6770_CR25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3109\/0886022X.2011.648596","volume":"34","author":"O Duzen","year":"2012","unstructured":"Duzen O, Erkoc R, Begenik H, Soyoral YU, Aldemir MN. The course of hypercalciuria and related markers of bone metabolism parameters associated with corticosteroid treatment. Ren Fail. 2012;34(3):338\u201342.","journal-title":"Ren Fail"},{"issue":"1","key":"6770_CR26","first-page":"F30","volume":"239","author":"HN Hulter","year":"1980","unstructured":"Hulter HN, Licht JH, Bonner EL Jr, Glynn RD, Sebastian A. Effects of glucocorticoid steroids on renal and systemic acid-base metabolism. Am J Physiol. 1980;239(1):F30-43.","journal-title":"Am J Physiol"},{"issue":"1","key":"6770_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1046\/j.1523-1755.2000.00155.x","volume":"58","author":"S Aruga","year":"2000","unstructured":"Aruga S, Wehrli S, Kaissling B, et al. Chronic metabolic acidosis increases NaDC-1 mRNA and protein abundance in rat kidney. Kidney Int. 2000;58(1):206\u201315.","journal-title":"Kidney Int"},{"issue":"3","key":"6770_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.semarthrit.2015.06.017","volume":"45","author":"CB Ligon","year":"2015","unstructured":"Ligon CB, Hummers LK, McMahan ZH. Oxalate nephropathy in systemic sclerosis: case series and review of the literature. Semin Arthritis Rheum. 2015;45(3):315\u201320.","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"6770_CR29","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.ekir.2020.06.021","volume":"5","author":"B Buysschaert","year":"2020","unstructured":"Buysschaert B, Aydin S, Morelle J, Gillion V, Jadoul M, Demoulin N. Etiologies, clinical features, and outcome of oxalate nephropathy. Kidney Int Rep. 2020;5(9):1503\u20139.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"6770_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.ajkd.2013.09.010","volume":"63","author":"A Cohen-Bucay","year":"2014","unstructured":"Cohen-Bucay A, Garimella P, Ezeokonkwo C, Bijol V, Strom JA, Jaber BL. Acute oxalate nephropathy associated with Clostridium difficile colitis. Am J Kidney Dis. 2014;63(1):113\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"6770_CR31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/0310057X0803600413","volume":"36","author":"GJ McHugh","year":"2008","unstructured":"McHugh GJ, Graber ML, Freebairn RC. Fatal vitamin C-associated acute renal failure. Anaesth Intensive Care. 2008;36(4):585\u20138.","journal-title":"Anaesth Intensive Care"},{"issue":"2","key":"6770_CR32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1378\/chest.118.2.561","volume":"118","author":"S Mashour","year":"2000","unstructured":"Mashour S, Turner JF Jr, Merrell R. Acute renal failure, oxalosis, and vitamin C supplementation: a case report and review of the literature. Chest. 2000;118(2):561\u20133.","journal-title":"Chest"},{"issue":"6","key":"6770_CR33","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0022-5347(17)35888-3","volume":"150","author":"P Barcelo","year":"1993","unstructured":"Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol. 1993;150(6):1761\u20134.","journal-title":"J Urol"},{"issue":"3","key":"6770_CR34","first-page":"193","volume":"24","author":"WF Caspary","year":"1977","unstructured":"Caspary WF, T\u00f6nissen J, Lankisch PG. \u201cEnteral\u201d hyperoxaluria. Effect of cholestyramine, calcium, neomycin, and bile acids on intestinal oxalate absorption in man. Acta Hepatogastroenterol (Stuttg). 1977;24(3):193\u2013200.","journal-title":"Acta Hepatogastroenterol (Stuttg)"},{"issue":"19","key":"6770_CR35","doi-asserted-by":"publisher","first-page":"e6758","DOI":"10.1097\/MD.0000000000006758","volume":"96","author":"N Demoulin","year":"2017","unstructured":"Demoulin N, Issa Z, Crott R, et al. Enteric hyperoxaluria in chronic pancreatitis. Med. 2017;96(19):e6758.","journal-title":"Med"},{"issue":"1","key":"6770_CR36","first-page":"89","volume":"149","author":"B Nordenvall","year":"1983","unstructured":"Nordenvall B, Backman L, Burman P, Larsson L, Tiselius HG. Low-oxalate, low-fat dietary regimen in hyperoxaluria following jejunoileal bypass. Acta Chir Scand. 1983;149(1):89\u201391.","journal-title":"Acta Chir Scand"},{"issue":"1","key":"6770_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1172\/JCI63679","volume":"123","author":"SR Mulay","year":"2013","unstructured":"Mulay SR, Kulkarni OP, Rupanagudi KV, et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1\u03b2 secretion. J Clin Invest. 2013;123(1):236\u201346.","journal-title":"J Clin Invest"},{"issue":"5","key":"6770_CR38","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1001\/archinte.1985.00360050220044","volume":"145","author":"JM Lawton","year":"1985","unstructured":"Lawton JM, Conway LT, Crosson JT, Smith CL, Abraham PA. Acute oxalate nephropathy after massive ascorbic acid administration. Arch Intern Med. 1985;145(5):950\u20131.","journal-title":"Arch Intern Med"},{"issue":"9","key":"6770_CR39","first-page":"1245","volume":"8","author":"N Potere","year":"2023","unstructured":"Potere N, Abbate A, Kanthi Y, et al. Inflammasome signaling, thromboinflammation, and venous thromboembolism. JACC: Basic to Translational Science. 2023;8(9):1245\u201361.","journal-title":"JACC: Basic to Translational Science"},{"issue":"1","key":"6770_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/ndt\/gfi153","volume":"21","author":"RM Perkins","year":"2006","unstructured":"Perkins RM, Reynolds JC, Ahuja TS, et al. Thrombotic microangiopathy in United States long-term dialysis patients. Nephrol Dial Transplant. 2006;21(1):191\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"35","key":"6770_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039431","volume":"103","author":"G Dong","year":"2024","unstructured":"Dong G, Gao P, Shi FE, Yu J, Zhu J. Acute kidney injury associated with thrombotic microangiopathy: characterization, prevalence, and prognosis. Med (Baltimore). 2024;103(35):e39431.","journal-title":"Med (Baltimore)"},{"issue":"12 Suppl 3","key":"6770_CR42","doi-asserted-by":"publisher","first-page":"S274","DOI":"10.1681\/ASN.2006080926","volume":"17","author":"R Jofr\u00e9","year":"2006","unstructured":"Jofr\u00e9 R, Rodriguez-Benitez P, L\u00f3pez-G\u00f3mez JM, P\u00e9rez-Garcia R. Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol. 2006;17(12 Suppl 3):S274-80.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"6770_CR43","first-page":"404","volume":"34","author":"P Karmacharya","year":"2016","unstructured":"Karmacharya P, Donato AA, Aryal MR, et al. RS3PE revisited: a systematic review and meta-analysis of 331 cases. Clin Exp Rheumatol. 2016;34(3):404\u201315.","journal-title":"Clin Exp Rheumatol"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06770-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-06770-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06770-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T20:01:50Z","timestamp":1767038510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-025-06770-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6770"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-06770-3","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Verbal informed consent for publication was obtained from the patient during her lifetime after full explanation of the purpose and contents of this case report. However, the patient had died by the time of manuscript preparation, and written informed consent could not be obtained. We made repeated and reasonable attempts to contact the patient\u2019s next of kin or other legal representatives to obtain written consent, but no relatives could be reached. All potentially identifiable information has been removed or anonymized as far as possible. The institutional ethics committee of Yokohama Sakae Hospital reviewed the case and approved publication without written consent in view of the scientific and educational value of the report (Approval No. 20251117\u20131).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1045"}}